✦ LIBER ✦

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice

✍ Scribed by Karen M. Smith; Samantha Matson; Wayne R. Matson; Kerry Cormier; Steven J. Del Signore; Sean W. Hagerty; Edward C. Stack; Hoon Ryu; Robert J. Ferrante

Book ID: 116270457
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 727 KB
Volume: 1762
Category: Article
ISSN: 0925-4439
DOI: 10.1016/j.bbadis.2006.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does High-Dose Coenzyme Q 10 Improve Oxi

Does High-Dose Coenzyme Q 10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?

✍ Seet, Raymond Chee-Seong; Lim, Erle C.H.; Tan, June J.H.; Quek, Amy M.L.; Chow, 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 437 KB

Safety and tolerability of high-dosage c

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects

✍ The Huntington Study Group Pre2CARE Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Safety and efficacy of coenzyme Q10 supp

Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study

✍ Safarinejad, M R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 577 KB

MP-07.12 Safety and Efficacy of Coenzyme

MP-07.12 Safety and Efficacy of Coenzyme Q10 Supplementation in Early Chronic Peyronie's Disease: A Double-Blind, Placebo-Controlled Randomized Study

✍ M. Safarinejad 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Safety and efficacy results of a phase I

Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Effectiveness and tolerability of high-d

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

✍ Martin R. Farlow; Stephen Salloway; Pierre N. Tariot; Jane Yardley; Margaret L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB